Outset Medical Net Worth
Outset Medical Net Worth Breakdown | OM |
Outset Medical Net Worth Analysis
Outset Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Outset Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Outset Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Outset Medical's net worth analysis. One common approach is to calculate Outset Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Outset Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Outset Medical's net worth. This approach calculates the present value of Outset Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Outset Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Outset Medical's net worth. This involves comparing Outset Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Outset Medical's net worth relative to its peers.
To determine if Outset Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Outset Medical's net worth research are outlined below:
| Outset Medical is way too risky over 90 days horizon | |
| Outset Medical appears to be risky and price may revert if volatility continues | |
| Outset Medical has high likelihood to experience some financial distress in the next 2 years | |
| The company generated the yearly revenue of 113.69 M. Annual Net Loss to common stockholders was (127.98 M) with gross profit of 41.69 M. | |
| Outset Medical reports about 227.52 M in cash with (116.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.71. | |
| Outset Medical has a very weak financial position based on the latest SEC disclosures | |
| Over 83.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Financial Review Outset Medical versus Fulgent Genetics |
Outset Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Outset Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Outset Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Outset Medical Target Price Consensus
Outset target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Outset Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 5 | Strong Buy |
Most Outset analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Outset stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Outset Medical, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationOutset Medical Target Price Projection
Outset Medical's current and average target prices are 20.90 and 26.50, respectively. The current price of Outset Medical is the price at which Outset Medical is currently trading. On the other hand, Outset Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Outset Medical Market Quote on 6th of July 2025
Target Price
Analyst Consensus On Outset Medical Target Price
Know Outset Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Outset Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Outset Medical backward and forwards among themselves. Outset Medical's institutional investor refers to the entity that pools money to purchase Outset Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Schonfeld Strategic Advisors Llc | 2025-03-31 | 190.2 K | Vanguard Group Inc | 2025-03-31 | 173.3 K | Catalio Capital Management, Lp | 2025-03-31 | 166.7 K | Millennium Management Llc | 2025-03-31 | 115.1 K | Gmt Capital Corp | 2025-03-31 | 98.1 K | Acadian Asset Management Llc | 2025-03-31 | 89.3 K | Ensign Peak Advisors Inc | 2025-03-31 | 84.5 K | Cam Group Holding A/s | 2025-03-31 | 66.7 K | Blackrock Inc | 2025-03-31 | 65.9 K | Fmr Inc | 2025-03-31 | 2.6 M | Durable Capital Partners Lp | 2025-03-31 | 1.7 M |
Follow Outset Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a market capitalization of 370.4 M.Project Outset Medical's profitablity
The company has Net Profit Margin (PM) of (0.99) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.55) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.55.When accessing Outset Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Outset Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Outset Medical's profitability and make more informed investment decisions.
Evaluate Outset Medical's management efficiency
Outset Medical has Return on Asset (ROA) of (0.1741) % which means that for every 100 dollars spent on asset, it generated a loss of $0.1741. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.8653) %, which implies that it produced no returns to current stockholders. Outset Medical's management efficiency ratios could be used to measure how well Outset Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Outset Medical's Total Assets are very stable compared to the past year. As of the 6th of July 2025, Net Tangible Assets is likely to grow to about 297 M, while Other Assets are likely to drop about 4.9 M.Outset Medical has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.
Enterprise Value Revenue 2.4585 | Revenue | Quarterly Revenue Growth 0.056 | Revenue Per Share 26.35 | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Outset Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Outset Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Outset Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Outset Medical time-series forecasting models is one of many Outset Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Outset Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Outset Medical Earnings per Share Projection vs Actual
Outset Medical Corporate Management
| Laura Romike | Senior Sales | Profile | |
| Jennifer Sipple | Senior Experience | Profile | |
| Stacey Porter | Chief Officer | Profile | |
| Mark MS | Chief Officer | Profile | |
| Steven Williamson | Chief Officer | Profile | |
| Marc Nash | Senior RD | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Outset Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Outset Medical. If investors know Outset will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Outset Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (28.79) | Revenue Per Share 26.35 | Quarterly Revenue Growth 0.056 | Return On Assets (0.17) | Return On Equity |
The market value of Outset Medical is measured differently than its book value, which is the value of Outset that is recorded on the company's balance sheet. Investors also form their own opinion of Outset Medical's value that differs from its market value or its book value, called intrinsic value, which is Outset Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Outset Medical's market value can be influenced by many factors that don't directly affect Outset Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Outset Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Outset Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.